Sign In
Buy BMRA
$1.49
-0.0999 (-6.28%)
At Close: Jul 31, 2026
Biomerica (NASDAQ:BMRA) Stock Crosses Below 200-Day Moving Average – What’s Next?
03:44am, Wednesday, 17'th Dec 2025
Biomerica, Inc. (NASDAQ: BMRA - Get Free Report)'s share price passed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $2.96 and traded as low as $
Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio
08:08am, Thursday, 11'th Dec 2025
Authorization Covers Multiple Screening Tests for Cancer and Chronic Disease Risk Detection • Portfolio includes tests for colorectal disease, breast self exam, prostate disease, kidney disease, and
IRVINE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical diagnostic solutions, is proud to announce that its inFoods® IBS diagnostic-gui
Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand
08:19am, Thursday, 06'th Nov 2025
IRVINE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical diagnostic solutions, today announced the expansion of its Contract Development
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods® IBS Test in the U.S.
08:19am, Thursday, 16'th Oct 2025
- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation's Most Trusted Health Care Distributors - Relationship Marks a Key Milestone in Biomerica's Commercialization Stra
Biomerica Reports First Quarter Fiscal 2026 Financial Results
09:27am, Wednesday, 15'th Oct 2025
Reported Improved Gross Margin from Contribution from Higher-Margin Product Mix Operating Expenses Continued to Decline Compared to the First Quarter of the Prior Fiscal Year, Reflecting the Company's
Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors
08:19am, Wednesday, 08'th Oct 2025
IRVINE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global provider of advanced diagnostic solutions, today announced the appointment of Gary Huff to its Board of Direct
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Test for Home Use
08:19am, Wednesday, 03'rd Sep 2025
IRVINE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic solutions, announced today announced that the United Arab Emirates (UAE) Min
Biomerica Reports Fiscal 2025 Year End Results
05:12pm, Friday, 29'th Aug 2025
$1.3 Million in Operating Expense Reductions Achieved– Operating Loss Improves 19% Year-Over-Year Resilient Portfolio Performance with International Sales Despite Global Economic Uncertainties Cash
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Home Use
08:19am, Thursday, 14'th Aug 2025
IRVINE, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic solutions, today announced that the United Arab Emirates (UAE) Ministry of He
InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code
08:08am, Wednesday, 02'nd Jul 2025
IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company focused on innovative gastroenterology diagnostics, today announced that the American Medi
Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer
08:19am, Thursday, 26'th Jun 2025
IRVINE, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment o
Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair
09:30am, Friday, 06'th Jun 2025
Mr. Chin brings over 20 years of financial experience across public and private healthcare organizations Mr. Chin currently serves as CFO of Akido Labs where he successfully helped raise $60 million i
Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology
08:19am, Thursday, 05'th Jun 2025
IRVINE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global leader in advanced diagnostic-guided therapies, today announced that data from its pivotal clinical trial eva
IRVINE, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), an innovator in diagnostic-guided therapy, today announced compelling real-world results demonstrating the effectivenes
